Blog
RSS FeedPosted by Michael Wonder on 04 Oct 2020
Budget to deliver better access to life changing medicines for liver cancer, eye conditions and Parkinson’s disease
4 October 2020 - In Tuesday’s Budget, the Morrison Government will provide significant investment for new medicines including over $230 million ...
Posted by Michael Wonder on 03 Sep 2020
The mother of three on her last chance to beat blood cancer
2 September 2020 - Deb Sims knows she’s on her last chance to beat the blood cancer that has dogged ...
Posted by Michael Wonder on 31 Aug 2020
New hope for Australian leukaemia and lymphoma patients with key treatment option listed on PBS
31 August 2020 - A key new cancer treatment has just become more accessible for Australians fighting specific forms of leukaemia ...
Posted by Michael Wonder on 23 Aug 2020
Prostate cancer treatment Nubeqa made available for free in Australia by Bayer
23 August 2020 - Prostate cancer kills more than 3,000 men a year in Australia. But now many will have access ...
Posted by Michael Wonder on 02 Aug 2020
Schedule of Pharmaceutical Benefits - 1 August 2020
1 August 2020 - The August 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Aug 2020
Australians with cancer, infants with epilepsy to benefit from PBS listings
1 August 2020 - Australians with certain cancers and infants with severe epilepsy will benefit from new medications being listed or ...
Posted by Michael Wonder on 19 Jul 2020
PBAC asks Roche for another comparison for Tecentriq
20 July 2020 - The submission requested a PBS (Section 100) listing for atezolizumab for use in combination with taxane chemotherapy ...
Posted by Michael Wonder on 16 Jul 2020
Mallinckrodt and Terumo BCT announce positive recommendations for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos CE
13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...
Posted by Michael Wonder on 01 Jun 2020
New combination therapy now reimbursed for Australians living with incurable blood cancer
1 June 2020 - New combination therapy now reimbursed for Australians living with incurable blood cancer. ...
Posted by Michael Wonder on 04 May 2020
Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy
1 May 2020 - The reimbursement of the immune checkpoint inhibitors is challenging. ...
Posted by Michael Wonder on 02 Apr 2020
Blood cancer treatment added to PBS
1 April 2020 - Nearly a decade after doctors told him he had up to six years to live, Ian ...
Posted by Michael Wonder on 01 Mar 2020
Government strengthens support for melanoma patients with breakthrough treatment expanded on PBS
1 March 2020 - The start of autumn will bring with it a new sense of hope for over 2,000 Australians ...
Posted by Michael Wonder on 29 Feb 2020
Melanoma medicine added to the Pharmaceutical Benefits Scheme
29 February 2020 - A host of melanoma treatments have been added to the Pharmaceutical Benefits Scheme, slashing costs for patients ...
Posted by Michael Wonder on 27 Feb 2020
New drug added to PBS to help treat Australia's deadliest cancer
26 February 2020 - Rhonda Lumsden was suffering from stage 4 lung cancer and out of options, when a new ...
Posted by Michael Wonder on 19 Feb 2020
New hope for lung cancer patients with ground-breaking treatment option to be listed on the PBS
19 February 2020 - Australians with non-small cell and small cell lung cancer or chronic obstructive pulmonary disease will benefit from ...